Cardiac SPECT

Single photon emission computed tomography (SPECT) is a nuclear imaging modality that uses injected radiotracers to image heart cell metabolism to show functional information on the heart. Cardiac SPECT is used for myocardial perfusion imaging (MPI) and represents the vast majority of nuclear cardiologic imaging exams each year. It is used to determine if a patient has ischemia or an infarct and if revascularization of the coronary arteries will help the patient experiencing chest pain or a heart attack. The FDA has approved four radiotracers for MPI, including thallium-201, 99mTc-Sestamibi, 99mTc-Tetrofosmin, and 99mTc-Teboroxime.

chest pain lung pulmonary embolism

CCTA is a safe, effective alternative to SPECT in patients with stable chest pain

The findings come by way of the RESCUE Trial, which included more than 1,000 participants from 44 different sites.

December 8, 2020

ASNC monitoring potential Mo-99 supply shortages due to COVID-19

The president of the American Society of Nuclear Cardiology said there are no shortfalls reported at this time, but the organization is keeping an eye on the situation as more countries implement travel bans.

March 16, 2020
SNMMI

SNMMI backs updated ASNC guidelines on SPECT MPI

New 2018 guidelines for myocardial perfusion imaging (MPI) protocols on conventional and novel single photon emission computed tomography (SPECT) for nuclear cardiology practitioners has received praise from the Society for Nuclear Medicine and Molecular Imaging (SNMMI).

June 21, 2018